# Encore Vision, Inc.: Form D filings

Encore Vision, Inc., a pharmaceuticals company in Fort Worth, TX, filed 4 Form D notices with the SEC between 2014 and 2016. The latest, on May 13, 2016, reports $4.5 million sold of a $4.5 million offering to 48 investors.

Find out what Encore Vision, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Encore%20Vision%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Encore%20Vision%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fencore-vision-inc-1618596)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Encore%20Vision%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Encore%20Vision%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fencore-vision-inc-1618596)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1120 SOUTH FREEWAY, SUITE 118, Fort Worth, TX, 76104
- Phone: (817) 454-9049
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1618596

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 13, 2016 | Amendment | $4,500,000 | $4,500,000 | $0 | 48 | Aug 21, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1618596/000161859616000003/0001618596-16-000003-index.htm) |
| Aug 25, 2015 | New notice | $2,500,000 | $2,500,000 | $0 | 34 | Aug 21, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1618596/000161859615000002/0001618596-15-000002-index.htm) |
| Feb 9, 2015 | New notice | $1,116,224 | $1,116,224 | $0 | 22 | Feb 3, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1618596/000161859615000001/0001618596-15-000001-index.htm) |
| Sep 17, 2014 | New notice | $1,700,000 | $1,680,106 | $19,894 | 29 | Sep 5, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1618596/000161859614000001/0001618596-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Richard R. Lindstrom | Director |  |
| William R. Burns | Executive Officer, Director |  |
| Les R. Kreis | Director |  |
| John R. Hunkeler | Director |  |
| Adrienne R. Graves | Director |  |
| William Ed Tyler | Director |  |
| Peter R. Bennett | Director |  |

## Other pharmaceuticals companies in Texas that filed recently

- [LUCIER PHARMACEUTICALS INC](https://specstream.ai/data/form-d/company/lucier-pharmaceuticals-inc-2158290) offering · Oct 13, 2026
- [FibroBiologics, Inc.](https://specstream.ai/data/form-d/company/fibrobiologics-inc-1958777) $1.2 million · Oct 13, 2026
- [Eos SENOLYTIX, Inc.](https://specstream.ai/data/form-d/company/eos-senolytix-inc-2129803) $750,000 · Aug 27, 2026

[Every Form D from the week of May 9, 2016](https://specstream.ai/data/form-d/week/2016-05-09) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Encore Vision, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).